One page, thousands of outlets. See who else covered it.
Argenx said Monday that Vyvgart Hytrulo passed a late-stage test in a family of rare autoimmune diseases, even though the drug missed the mark in a key patient subgroup. The subcutaneous drug
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Mumbai: The Bombay High Court has directed the Maharashtra Food and Drug Administration (FDA) to pay Rs 5 lakh compensation to a Pune sweets shop for failing to revoke its licence suspension despite…
AstraZeneca has ended a Phase 3 study of one of its cancer drugs, the latest in a string of setbacks the drugmaker has endured. The company said Monday it was discontinuing ...
[allAfrica] Geneva -- Agencies fighting the escalating Ebola virus in the Democratic Republic of Congo (DRC) constantly battle to win the trust of local communities, say international groups in the…
Nashik: To ensure that citizens have access to safe, hygienic, and high-quality food, the Food and Drug Administration (FDA) conducted inspections of various establishments in Nashik city and the…
[Bhekisisa] His wheelchair no longer fits, and the local clinic often runs out of his medicine. Add to that three decades of living with cerebral palsy.
A recent study indicates that people from lower-class backgrounds are less likely to negotiate their salaries. When they do ask for more, they tend to face stronger social backlash from employers…